How Do We Manage HLA-B27-associated Ocular Inflammation Refractory or Intolerant to Conventional Immunomodulatory Therapy?

J Ophthalmic Vis Res. 2020 Oct 25;15(4):442-445. doi: 10.18502/jovr.v15i4.7777. eCollection 2020 Oct-Dec.
No abstract available

Publication types

  • Editorial